These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36847240)

  • 21. Analysis of Differential Expression of Synaptic Vesicle Protein 2A in the Adult Rat Brain.
    Mendoza-Torreblanca JG; García-Cruz ME; Sánchez-Cruz I; Gomez-Gonzalez B; Juárez-Méndez S; Gómez-Lira G
    Neuroscience; 2019 Nov; 419():108-120. PubMed ID: 31520710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential of [
    Puuvuori E; Rokka J; Carlsson PO; Li Z; Eriksson J; Eriksson O
    Sci Rep; 2021 Dec; 11(1):24466. PubMed ID: 34963683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of Synaptic Density in Neurodegenerative Disorders.
    Carson RE; Naganawa M; Toyonaga T; Koohsari S; Yang Y; Chen MK; Matuskey D; Finnema SJ
    J Nucl Med; 2022 Jun; 63(Suppl 1):60S-67S. PubMed ID: 35649655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET.
    Mecca AP; Chen MK; O'Dell RS; Naganawa M; Toyonaga T; Godek TA; Harris JE; Bartlett HH; Zhao W; Nabulsi NB; Wyk BCV; Varma P; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    Alzheimers Dement; 2020 Jul; 16(7):974-982. PubMed ID: 32400950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET).
    Rossano S; Toyonaga T; Berg E; Lorence I; Fowles K; Nabulsi N; Ropchan J; Li S; Ye Y; Felchner Z; Kukis D; Huang Y; Benveniste H; Tarantal AF; Groman S; Carson RE
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3679-3691. PubMed ID: 35633376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of pre-synaptic density networks using [
    Akkermans J; Zajicek F; Miranda A; Adhikari MH; Bertoglio D
    Neuroimage; 2022 Dec; 264():119771. PubMed ID: 36436710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hippocampal low-frequency stimulation increased SV2A expression and inhibited the seizure degree in pharmacoresistant amygdala-kindling epileptic rats.
    Wang L; Shi J; Wu G; Zhou F; Hong Z
    Epilepsy Res; 2014 Nov; 108(9):1483-91. PubMed ID: 25205164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
    Onwordi EC; Halff EF; Whitehurst T; Mansur A; Cotel MC; Wells L; Creeney H; Bonsall D; Rogdaki M; Shatalina E; Reis Marques T; Rabiner EA; Gunn RN; Natesan S; Vernon AC; Howes OD
    Nat Commun; 2020 Jan; 11(1):246. PubMed ID: 31937764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [(11)C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A.
    Estrada S; Lubberink M; Thibblin A; Sprycha M; Buchanan T; Mestdagh N; Kenda B; Mercier J; Provins L; Gillard M; Tytgat D; Antoni G
    Nucl Med Biol; 2016 Jun; 43(6):325-32. PubMed ID: 27260773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic evaluation and test-retest reproducibility of [
    Finnema SJ; Nabulsi NB; Mercier J; Lin SF; Chen MK; Matuskey D; Gallezot JD; Henry S; Hannestad J; Huang Y; Carson RE
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):2041-2052. PubMed ID: 28792356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SV2A PET Imaging Is a Noninvasive Marker for the Detection of Spinal Damage in Experimental Models of Spinal Cord Injury.
    Bertoglio D; Halloin N; Lombaerde S; Jankovski A; Verhaeghe J; Nicaise C; Staelens S
    J Nucl Med; 2022 Aug; 63(8):1245-1251. PubMed ID: 35027368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medial dorsal striatum is more sensitive than lateral dorsal striatum to cocaine inhibition of exogenous dopamine clearance: relation to [3H]mazindol binding, but not striosome/matrix.
    Cline EJ; Adams CE; Larson GA; Gerhardt GA; Zahniser NR
    Exp Neurol; 1995 Jul; 134(1):135-49. PubMed ID: 7672034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of repeated cocaine administration on the thyrotropin-releasing hormone level and receptors in the rat brain.
    Jaworska-Feil L; Budziszewska B; Lasoń W
    Neuropeptides; 1997 Jun; 31(3):253-8. PubMed ID: 9243522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens.
    Sharpe LG; Pilotte NS; Mitchell WM; De Souza EB
    Eur J Pharmacol; 1991 Oct; 203(1):141-4. PubMed ID: 1797552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.
    Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ
    J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring with [
    Serrano ME; Bahri MA; Becker G; Seret A; Germonpré C; Lemaire C; Giacomelli F; Mievis F; Luxen A; Salmon E; Rogister B; Raedt R; Plenevaux A
    Mol Imaging Biol; 2020 Oct; 22(5):1197-1207. PubMed ID: 32206990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration.
    Wilson JM; Nobrega JN; Carroll ME; Niznik HB; Shannak K; Lac ST; Pristupa ZB; Dixon LM; Kish SJ
    J Neurosci; 1994 May; 14(5 Pt 2):2966-79. PubMed ID: 8182452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.
    Tokudome K; Okumura T; Shimizu S; Mashimo T; Takizawa A; Serikawa T; Terada R; Ishihara S; Kunisawa N; Sasa M; Ohno Y
    Sci Rep; 2016 Jun; 6():27420. PubMed ID: 27265781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of heterocyclic nonacetamide synaptic vesicle protein 2A (SV2A) ligands with single-digit nanomolar potency: opening avenues towards the first SV2A positron emission tomography (PET) ligands.
    Mercier J; Archen L; Bollu V; Carré S; Evrard Y; Jnoff E; Kenda B; Lallemand B; Michel P; Montel F; Moureau F; Price N; Quesnel Y; Sauvage X; Valade A; Provins L
    ChemMedChem; 2014 Apr; 9(4):693-8. PubMed ID: 24446373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
    van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
    Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.